beta-lactamase OXA-48, Proteus mirabilis

Known as: OXA-48 beta-lactamase, Proteus mirabilis 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
01220112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Although the New York/New Jersey (NY/NJ) area is an epicenter for carbapenem-resistant Enterobacteriaceae (CRE), there are few… (More)
Is this relevant?
2017
2017
We aimed to characterize carbapenem-resistant isolates in a tertiary hospital in Istanbul, Turkey, high-prevelance area for OXA… (More)
Is this relevant?
Review
2015
Review
2015
To the Editor Carbapenems (i.e. ertapenem, imipenem, meropenem, and doripenem) are second line antimicrobials reserved to treat… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
OBJECTIVES Carbapenem-hydrolysing class D β-lactamases of the OXA-48 type are increasingly reported from Enterobacteriaceae… (More)
  • figure 1
Is this relevant?
2014
2014
OBJECTIVE To detect genes encoding carbapenem resistance in urinary isolates of Escherichia coli recovered from hospitalized… (More)
Is this relevant?
2013
2013
OBJECTIVES The proliferation of carbapenemases in Enterobacteriaceae demands new therapies, with current interest centred on… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 2
Is this relevant?
2012
2012
The objective of this study was to investigate the in vitro antibacterial activity of avibactam (formerly NXL104) in combination… (More)
  • table 1
Is this relevant?
2011
2011
Sir, The emergence and dissemination of Klebsiella pneumoniae isolates harbouring carbapenemases is a serious problem. Since the… (More)
Is this relevant?